Europa Stream

 

Elysium Healthcare expands eating disorder care services with acquisition of Vivre Care

Elysium Healthcare, a UK-based mental health service provider which is part of Australian group Ramsay Health Care, has expanded its provision of specialist eating disorder services with the acquisition of Vivre Care, a residential care provider. Vivre Care provides specialist support for people with severe eating disorders, with its services “aligning with the NHS strategy of prioritising community-based treatment”.

Investors eye Malaysia and Southeast Asia’s strengthening digital health markets

Malaysia's digital healthcare transformation started with the introduction of the National Telemedicine Blueprint in 1997. The country has been slow in progressing but opportunities for investments are increasing in recent years. The aim is to have a nationwide Electronic Medical Record (EMR) system by 2026. The Ministry of Science, Technology, and Innovation (MOSTI) launched the Technology and Innovation Sandbox in 2020 to accelerate digitalisation across socio-economic sectors in Malaysia. As of 2021 data, healthcare has been a primary beneficiary, receiving highest tech support. 

Synlab sells Spanish division to Eurofins as part of long term divestment strategy

Pan-European diagnostic labs group Synlab is continuing to divest divisions of its business located in less profitable markets to divert resources towards more profitable markets. It is selling its Spanish division to Eurofins, a major listed multinational labs group, and is also attempting to sell its Romanian division.

Portobello acquires minority stake in Clínicas Mi

Portobello Capital, a mid-market private equity firm based in Spain, has acquired a minority stake in Clínicas Mi, a Catalan private hospital group, to ‘drive its expansion through organic growth and strategic acquisitions’. With the goal of doubling its revenue and reaching €100 million in a few years, Clínicas Mi, led by the Masfurroll family, will continue to grow with Portobello’s support. 

Kry simplifies shareholder structure to facilitate expansion

Swedish digi-physical healthcare company Kry has voted to significantly simplify its shareholder structure by reducing the number of categories of shares it has and converting most of its preference shares into ordinary shares.

Sanofi and CD&R enter exclusive agreement for Opella sale, and promise to keep jobs in France

French pharma giant Sanofi and US PE firm Clayton Dubilier & Rice (CD&R) have been made to sign a promise to the French government to keep factories and jobs in France after the sale of a 50% stake in Sanofi's consumer health division, Opella, to CD&R. Sanofi and CD&R are now in exclusive talks for the sale, in a deal which is valuing Opella at $16.4 billion.

UK’s care home sector presents “stable and promising investment opportunity”

The real estate of Care UK, the fourth largest for-profit care home provider in the UK by revenue, has been sold by British private equity firm Bridgepoint to US-based real estate investment trust (REIT) Welltower. Bridgepoint acquired Care UK for £420 million in 2010, expanding its portfolio from 59 to 163 homes and increasing the proportion of private-pay residents from 5% to over 50%.

Bupa UK offers genome sequencing to selected customers

Bupa is to become the first private healthcare provider in the UK to offer genome sequencing. In a new two-year pilot scheme called ‘My Genomic Health’ the group will offer full genome sequencing to more than 3,500 Bupa UK customers. 

India’s healthcare IPO market grows, presenting fresh opportunities for investors

Niva Bupa Health Insurance, an India-based health insurance firm backed by private equity firm True North, and Paras Healthcare, one of the top Indian private hospitals, have received the Securities and Exchange Board of India’s (SEBI) approval to launch Initial Public Offerings (IPOs). Niva Bupa aims to raise ₹3,000 crore ($361 million USD), comprising Rs 800 crore ($96.4 million USD), through fresh equity and ₹2,200 crore ($264 million USD) via an Offer for Sale (OFS). The Times of India reported in July 2024 that Niva Bupa is “the second standalone health insurer to file an IPO, after Star Health & Allied Insurance Company”, India’s leading health insurer. 

Find Us